INTRODUCTION
Bleomycin is an antibiotic reagent with anti-tumor, anti-viral and antibacterial properties. Bleomycin is generally used in multi-drug chemotherapy due to its minimum bone marrow and immune system depression and is considered as a typical cytotoxic anti-neoplastic agent (1) . Nonetheless, administration of Bleomycin may result in severe and chronic pulmonary fibrosis. DNA conjugation and production of superoxide apart from other oxygen activated reagents and hydroxyl radicals, are reported as bleomycin mechanisms of action (2, 3) . It is assumed that this abnormality is a marker of inflammatory response in the alveolus. In one type of alveolus damage interstitial edema and accumulation of inflammatory cells occur (alveolitis) (4) 
TANAFFOS
prevention of diabetic complication (7), anti-neoplastic effect on breast and uterine cancer cells in vitro (10-100 µg/ml concentration) (8) , benzodiazepine-like activity (9) and phosphodiestrase inhibitory action (leads to increased cAMP levels) (10 (11) (12) (13) .
The aim of the present study was to evaluate the antiinflammatory and anti-oxidant effects of M. chamomilla plant in bleomycin-induced pulmonary fibrosis. 
MATERIALS AND METHODS

Experimental groups and treatment regimens
Experimental animals were divided into three major groups.
Group-I. Controlled animal group received intratracheal normal saline (n=5).
Group-ІІ. Animals received intratracheal bleomycin sulfate (n=5).
Group-ІІІ. Animals received M. chamomilla hydroalcoholic extract by oral gavages (400, 600, 800, 1000, 1500 mg/kg) for a period of two week after bleomycin sulfate intratracheal administration (n=5 for each dose).
The animals were anesthetized by thiopental (120 mg/kg). The control group received 0.2 ml normal saline, while groups ІІ and ІІІ received simultaneous intratracheal administration of 0.2 ml solution of bleomycin 7.5 U/ml dissolved in normal saline.
Histological evaluation
After a two weeks period the experimental animals were anesthetized with 0.3 ml thiopental (120 mg/kg) and scarified and then lungs were removed; the left lobe of lung tissue was fixed in 10% formalin solution for histological studies. In the next step a mid-sagittal section of each lung was prepared at 5 μm thickness and stained with Hematoxylin and Eosin (H&E). In order to evaluate the pathological grade caused by inflammation and fibrosis in the whole area and connective tissue changes apart from interstitial fluid particularly collagen, the prepared samples were stained with reticulin. In the following, the sections were evaluated by light microscopy.
Pharmacological experiments
In the recent study, isolated lung tissues were used for in-vivo pulmonary contractility study. After death, both heart and lungs were removed and maintained in Krebs 
Statistical analysis
After addition of contraction constituents to bath and obtaining pulmonary contraction responses, the tension (mg/mg weight) against concentration was plotted. In this study, the results were expressed as mean ± SD. Paired Student's t-test and analysis of variance were performed in order to determine the significant differences between means. P< 0.05 was considered statistically significant.
RESULTS
Histological results
After a two-week period of bleomycin intratracheal 
Pharmacological results
In the recent study, lung tissue in group receiving 1500 mg/kg Chamomile hydroalcoholic extract was studied in order to determine contractility. Control and fibrotic groups were compared for more pharmaco-mechanic Figure3. The comparison of lung strip contractility between control (given normal saline), given 1500 mg/kg extract, and Fibrotic groups *: P<0.05 significant made with control group, **: P<0.01 significant made with control group, *" :P<0.05 significant made with given 1500 mg/kg extract group, **": P<0.01 significant made with given 1500 mg/kg extract group The anti-inflammatory potential of Chamomilla recutita was shown clinically in patients with phlebitis due to antineoplastic chemotherapy (6) . Chamomile caused significant inhibition on proinflammatory cytokines production IL1β, IL-6 and TNF-α (14) . It was shown that
Chamomile is a selective COX-2 inhibitor with antiinflammatory activities (15) . All these data showed that
Chamomile has well-known anti-inflammatory and antioxidant activities. It was also demonstrated that antiinflammatory effects may be mediated through inhibition of Nitric Oxide (NO) production (14) .
Different studies were performed in regard to prevention and treatment of pulmonary fibrosis by administration of vitamin E (5) or non-steroidal antiinflammatory drugs such as indomethacin and diclofenac (13) . Since Chamomile plant contains great amounts of anti-inflammatory agents it can also be used to prevent and treat pulmonary fibrosis (11) .
In the recent studies, the effect of the Chamomile hydroalcoholic extract on pulmonary fibrosis was evaluated. They demonstrated that herbal flavonoids can inhibit the production of prostaglandins and leukotrienes in rat (14, 15) . Histological evaluation illustrates that the Less contractility at higher doses of the Chamomile hydroalcoholic extract was observed due to the inhibitory effect of extract on inflammatory mediators release, decrease in myofibroblasts and fibroblasts activity which consequently decrease collagen synthesis and fibrosis.
Although we have no ability to predict Chamomile extract mechanisms in the treatment of pulmonary fibrosis for certain, the antioxidant and anti-inflammatory of Chamomile extract particularly due to presence of Chamazulene is evident and it inhibits collagen, leukotrienes and prostaglandins synthesis.
A part from medicinal properties, several reports has raised concern about the toxic effects of Chamomile such as allergic reactions following oral administration (20) and contact dermatitis following topical applications (21, 22) .
Furthermore, Chamomile preparations contain components, especially chamazulene, Cis-spiroether and trans spiroether which showed in vitro inhibitory activities of major human drug metabolizing enzymes (23) . Thus, the potential of interaction between Chamomile and drugs should be considered.
In the present study the anti-inflammatory potential of Chamomilla recutita was shown. As a conclusion, administration of Chamomile extract due to its advantages is suggested in patients receiving long-term bleomycin sulfate or subjects exposed to fibrogenic materials or fibrotic damages.
